ArticleJournal of veterinary internal medicine
Cystoscopic-Guided Laser Ablation of Intramural Ectopic Ureters in Male Dogs: A Retrospective Study of 18 Cases (2011-2023).
Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Submucosal urethral bulking with 2.5% polyacrylamide hydrogel (Mictamid) for urinary incontinence in male dogs using a percutaneous fluoroscopically assisted perineal approach.Journal of veterinary internal medicine · 2026Article
- Cystoscopic-Guided Laser Ablation of Intramural Ectopic Ureters in Male Dogs: A Retrospective Study of 18 Cases (2011-2023).Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are limited studies on cystoscopic-guided laser ablation for treating ectopic ureters in male dogs. Further investigation is needed to assess its safety and efficacy. HYPOTHESIS/
objectiveRetrospectively describe long-term outcomes in male dogs treated using cystoscopic-guided laser ablation of ectopic ureters (CLA-EU). ANIMALS: Eighteen client-owned male dogs.
methodsMedical records of male dogs that had CLA-EU performed were retrospectively reviewed. Continence scores were assigned before and after the procedure. Data collected included signalment, neuter status, age of onset of urinary incontinence, pre- and post-operative continence scores, CBC, serum biochemistry, urinalysis, microbiological urine culture, pre- and post-operative abdominal imaging, EU laterality, concurrent anatomic anomalies, laser type and size used, procedure time, complications, and follow-up.
resultsThe procedure was performed successfully in all 28 ureters in the 18 dogs. Post-operative continence scores were significantly improved from pre-operative scores (p = 0.001). Four (22%) dogs were continent at the time of diagnosis. Of the 14 dogs initially incontinent, 11/14 (79%) became continent after CLA-EU without additional treatments, and an additional dog became continent with the addition of medications. Preoperatively, 14/28 kidneys and 17/28 ureters had evidence of hydronephrosis and hydroureter, respectively. Of the dogs, 10/14 with hydronephrosis and 12/17 with hydroureter showed improvement on post-operative ultrasonography. The median follow-up time was 1789 days (range, 98-3560). CONCLUSION AND CLINICAL IMPORTANCE: In male dogs, CLA-EU was a safe, effective, and minimally invasive procedure with good to excellent short- and long-term outcomes, achieving continence in most dogs and improvement or stabilization of associated hydronephrosis and hydroureter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.